Skip to search formSkip to main contentSkip to account menu

GANU

Known as: 1-(2-Chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea, N-(2-chloroethyl)-N'-beta-D-glucopyranosyl-N-nitrosourea 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1985
1985
Although the antitumor effects of chloroethylnitrosoureas have been shown to be due primarily to DNA-DNA cross-linking by the… 
1985
1985
The tissue levels of two proteolytic enzymes, plasminogen activator and cathepsin B - like cysteine proteinase, which were found… 
1982
1982
The removal of DNA adducts is an essential step of DNA repair following exposure to chloroethylnitrosoureas. Adduct removal was… 
1982
1982
The antitumor activity of 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea (TA-077), a novel water-soluble… 
1982
1982
A new water-soluble nitrosourea derivative, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea (TA-077), was tested for… 
1981
1981
The antitumor activities of seventeen antitumor alkylating agents have been studied in the xenograft of human mammary carcinoma… 
1980
1980
A study was conducted to evaluate the antitumor activities of six nitrosourea derivatives against the xenograft of mammary breast… 
1977
1977
A newly synthesized water-soluble nitrosourea derivative, 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea (GANU; NSC… 
1977
1977
Antitumor activity and bone marrow toxicity of a new nitrosourea analog, 1-(beta-D-glucopyranosyl)-3-(2-chloroethyl)-3…